The Relevance of Multiple Sclerosis Cortical Lesions on Cortical Thinning and Their Clinical Impact As Assessed by 7.0-T MRI
Authors
Affiliations
Objective: This study aimed to investigate at 7.0-T MRI a) the role of multiple sclerosis (MS) cortical lesions in cortical tissue loss b) their relation to neurological disability.
Methods: In 76 relapsing remitting and 26 secondary progressive MS patients (N = 102) and 56 healthy subjects 7.0-T T-weighted images were acquired for lesion segmentation; 3.0-T T-weighted structural scans for cortical surface reconstruction/cortical thickness estimation. Patients were dichotomized based on the median cortical lesion volume in low and high cortical lesion load groups that differed by age, MS phenotype and degree of neurological disability. Group differences in cortical thickness were tested on reconstructed cortical surface. Patients were evaluated clinically by means of the Expanded Disability Status Scale (EDSS).
Results: Cortical lesions were detected in 96% of patients. White matter lesion load was greater in the high than in the low cortical lesion load MS group (p = 0.01). Both MS groups disclosed clusters (prevalently parietal) of cortical thinning relative to healthy subjects, though these regions did not show the highest cortical lesion density, which predominantly involved frontal regions. Cortical thickness decreased on average by 0.37 mm, (p = 0.002) in MS patients for each unit standard deviation change in white matter lesion volume. The odds of having a higher EDSS were associated with cortical lesion volume (1.78, p = 0.01) and disease duration (1.15, p < 0.001).
Conclusion: Cortical thinning in MS is not directly related to cortical lesion load but rather with white matter lesion volume. Neurological disability in MS is better explained by cortical lesion volume assessment.
Krijnen E, van Dam M, Bajrami A, Bouman P, Noteboom S, Barkhof F Ann Clin Transl Neurol. 2024; 12(1):121-136.
PMID: 39729590 PMC: 11752103. DOI: 10.1002/acn3.52261.
In vivo evidence for cell body loss in cortical lesions in people with multiple sclerosis.
Krijnen E, Lee H, Noteboom S, Chiang F, Steenwijk M, Schoonheim M Ann Clin Transl Neurol. 2024; 12(1):4-16.
PMID: 39673156 PMC: 11752088. DOI: 10.1002/acn3.52237.
Mirmosayyeb O, Yazdan Panah M, Mokary Y, Mohammadi M, Moases Ghaffary E, Shaygannejad V PLoS One. 2024; 19(12):e0312421.
PMID: 39637162 PMC: 11620670. DOI: 10.1371/journal.pone.0312421.
Marastoni D, Turano E, Tamanti A, Colato E, Pisani A, Scartezzini A Neurol Neuroimmunol Neuroinflamm. 2024; 11(5):e200265.
PMID: 38917380 PMC: 11203401. DOI: 10.1212/NXI.0000000000200265.
Xie Y, Yao Y, Shen N, Li Y, Zhu H, Lu J Quant Imaging Med Surg. 2024; 14(3):2614-2626.
PMID: 38545072 PMC: 10963848. DOI: 10.21037/qims-23-1395.